{"id":1686,"date":"2024-10-28T13:58:32","date_gmt":"2024-10-28T12:58:32","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/"},"modified":"2024-10-28T13:58:32","modified_gmt":"2024-10-28T12:58:32","slug":"des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/","title":{"rendered":"Des \u00e9tudes pr\u00e9cliniques testent une nouvelle th\u00e9rapie g\u00e9nique pour traiter la n\u00e9phropathie \u00e0 IgA"},"content":{"rendered":"<div>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2022\/kidney.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/hires\/2022\/kidney.jpg\" data-sub-html=\"Credit: Pixabay\/CC0 Public Domain\">\n<figure class=\"article-img\">\n<\/figure><\/div>\n<\/div>\n<p>La n\u00e9phropathie \u00e0 IgA est une maladie r\u00e9nale auto-immune et le compl\u00e9ment, un composant du syst\u00e8me immunitaire inn\u00e9, joue un r\u00f4le dans la pathogen\u00e8se de la maladie. Les chercheurs ont d\u00e9velopp\u00e9 et test\u00e9 une nouvelle th\u00e9rapie g\u00e9nique qui p\u00e9n\u00e8tre dans les cellules r\u00e9nales et leur permet de bloquer l&rsquo;activation du compl\u00e9ment. La recherche a \u00e9t\u00e9 pr\u00e9sent\u00e9e lors de l\u2019ASN Kidney Week 2024, qui s\u2019est tenue du 23 au 27 octobre.<\/p>\n<p>La th\u00e9rapie g\u00e9nique, appel\u00e9e PS-002, utilise un virus modifi\u00e9 pour traiter les cellules r\u00e9nales appel\u00e9es podocytes. L&rsquo;administration de PS-002 dans un mod\u00e8le murin de n\u00e9phropathie \u00e0 IgA a r\u00e9duit les signes de dysfonctionnement r\u00e9nal, r\u00e9duit les d\u00e9p\u00f4ts de compl\u00e9ment et am\u00e9lior\u00e9 les cicatrices r\u00e9nales et d&rsquo;autres caract\u00e9ristiques structurelles de la maladie r\u00e9nale. Chez les porcs, le traitement au PS-002 a entra\u00een\u00e9 une expression g\u00e9n\u00e9tique \u00e9lev\u00e9e et prolong\u00e9e dans les tissus r\u00e9naux, sans aucun probl\u00e8me de s\u00e9curit\u00e9.<\/p>\n<p>\u00ab\u00a0Nos donn\u00e9es d\u00e9montrent que cibler les podocytes pour moduler l&rsquo;activation du compl\u00e9ment est une strat\u00e9gie th\u00e9rapeutique efficace, et le PS-002 ouvre la voie pour devenir la premi\u00e8re th\u00e9rapie g\u00e9nique en d\u00e9veloppement pour le traitement de la n\u00e9phropathie \u00e0 IgA\u00a0\u00bb, a d\u00e9clar\u00e9 l&rsquo;auteur correspondant Ambra Cappelletto, Ph.D. , de Purespring Therapeutics, \u00e0 Londres.<\/p>\n<p>\u00ab\u00a0La plateforme de th\u00e9rapie g\u00e9nique de Purespring, illustr\u00e9e par le PS-002, d\u00e9montre que le mat\u00e9riel g\u00e9n\u00e9tique th\u00e9rapeutique peut \u00eatre d\u00e9livr\u00e9 avec une grande efficacit\u00e9 aux podocytes, ouvrant ainsi la voie \u00e0 une nouvelle modalit\u00e9 hautement diff\u00e9renci\u00e9e ayant le potentiel de traiter un large \u00e9ventail de maladies r\u00e9nales.\u00a0\u00bb<\/p>\n<p>                                        <!-- print only --><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>La n\u00e9phropathie \u00e0 IgA est une maladie r\u00e9nale auto-immune et le compl\u00e9ment, un composant du<\/p>\n","protected":false},"author":1,"featured_media":476,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[16,1041,1064,2008,2007,244,8,1042,1811,1063,1165,47],"class_list":["post-1686","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-maladies","tag-des","tag-etudes","tag-genique","tag-iga","tag-nephropathie","tag-nouvelle","tag-pour","tag-precliniques","tag-testent","tag-therapie","tag-traiter","tag-une","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Des \u00e9tudes pr\u00e9cliniques testent une nouvelle th\u00e9rapie g\u00e9nique pour traiter la n\u00e9phropathie \u00e0 IgA - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Des \u00e9tudes pr\u00e9cliniques testent une nouvelle th\u00e9rapie g\u00e9nique pour traiter la n\u00e9phropathie \u00e0 IgA - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"La n\u00e9phropathie \u00e0 IgA est une maladie r\u00e9nale auto-immune et le compl\u00e9ment, un composant du\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-28T12:58:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726448688_Les-bienfaits-cardiovasculaires-du-semaglutide-sont-maintenus-chez-les-personnes.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\"},\"headline\":\"Des \u00e9tudes pr\u00e9cliniques testent une nouvelle th\u00e9rapie g\u00e9nique pour traiter la n\u00e9phropathie \u00e0 IgA\",\"datePublished\":\"2024-10-28T12:58:32+00:00\",\"dateModified\":\"2024-10-28T12:58:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/\"},\"wordCount\":324,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726448688_Les-bienfaits-cardiovasculaires-du-semaglutide-sont-maintenus-chez-les-personnes.jpg\",\"keywords\":[\"des\",\"\u00e9tudes\",\"g\u00e9nique\",\"IgA\",\"n\u00e9phropathie\",\"nouvelle\",\"pour\",\"pr\u00e9cliniques\",\"testent\",\"th\u00e9rapie\",\"traiter\",\"une\"],\"articleSection\":[\"Les maladies\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/\",\"name\":\"Des \u00e9tudes pr\u00e9cliniques testent une nouvelle th\u00e9rapie g\u00e9nique pour traiter la n\u00e9phropathie \u00e0 IgA - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726448688_Les-bienfaits-cardiovasculaires-du-semaglutide-sont-maintenus-chez-les-personnes.jpg\",\"datePublished\":\"2024-10-28T12:58:32+00:00\",\"dateModified\":\"2024-10-28T12:58:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726448688_Les-bienfaits-cardiovasculaires-du-semaglutide-sont-maintenus-chez-les-personnes.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726448688_Les-bienfaits-cardiovasculaires-du-semaglutide-sont-maintenus-chez-les-personnes.jpg\",\"width\":1920,\"height\":1600,\"caption\":\"Les bienfaits cardiovasculaires du s\u00e9maglutide sont maintenus chez les personnes souffrant d'insuffisance r\u00e9nale, selon une \u00e9tude\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Des \u00e9tudes pr\u00e9cliniques testent une nouvelle th\u00e9rapie g\u00e9nique pour traiter la n\u00e9phropathie \u00e0 IgA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Des \u00e9tudes pr\u00e9cliniques testent une nouvelle th\u00e9rapie g\u00e9nique pour traiter la n\u00e9phropathie \u00e0 IgA - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/","og_locale":"fr_FR","og_type":"article","og_title":"Des \u00e9tudes pr\u00e9cliniques testent une nouvelle th\u00e9rapie g\u00e9nique pour traiter la n\u00e9phropathie \u00e0 IgA - RVH-Synergie.org","og_description":"La n\u00e9phropathie \u00e0 IgA est une maladie r\u00e9nale auto-immune et le compl\u00e9ment, un composant du","og_url":"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/","og_site_name":"RVH-Synergie","article_published_time":"2024-10-28T12:58:32+00:00","og_image":[{"width":1920,"height":1600,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726448688_Les-bienfaits-cardiovasculaires-du-semaglutide-sont-maintenus-chez-les-personnes.jpg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560"},"headline":"Des \u00e9tudes pr\u00e9cliniques testent une nouvelle th\u00e9rapie g\u00e9nique pour traiter la n\u00e9phropathie \u00e0 IgA","datePublished":"2024-10-28T12:58:32+00:00","dateModified":"2024-10-28T12:58:32+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/"},"wordCount":324,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726448688_Les-bienfaits-cardiovasculaires-du-semaglutide-sont-maintenus-chez-les-personnes.jpg","keywords":["des","\u00e9tudes","g\u00e9nique","IgA","n\u00e9phropathie","nouvelle","pour","pr\u00e9cliniques","testent","th\u00e9rapie","traiter","une"],"articleSection":["Les maladies"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/","url":"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/","name":"Des \u00e9tudes pr\u00e9cliniques testent une nouvelle th\u00e9rapie g\u00e9nique pour traiter la n\u00e9phropathie \u00e0 IgA - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726448688_Les-bienfaits-cardiovasculaires-du-semaglutide-sont-maintenus-chez-les-personnes.jpg","datePublished":"2024-10-28T12:58:32+00:00","dateModified":"2024-10-28T12:58:32+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726448688_Les-bienfaits-cardiovasculaires-du-semaglutide-sont-maintenus-chez-les-personnes.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726448688_Les-bienfaits-cardiovasculaires-du-semaglutide-sont-maintenus-chez-les-personnes.jpg","width":1920,"height":1600,"caption":"Les bienfaits cardiovasculaires du s\u00e9maglutide sont maintenus chez les personnes souffrant d'insuffisance r\u00e9nale, selon une \u00e9tude"},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/des-etudes-precliniques-testent-une-nouvelle-therapie-genique-pour-traiter-la-nephropathie-a-iga\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"Des \u00e9tudes pr\u00e9cliniques testent une nouvelle th\u00e9rapie g\u00e9nique pour traiter la n\u00e9phropathie \u00e0 IgA"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/1686","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=1686"}],"version-history":[{"count":0,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/1686\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/476"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=1686"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=1686"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=1686"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}